Biogen Inc. buy Royal Bank of Canada
Start price
09.02.26
/
50%
€167.00
Target price
09.02.27
€197.12
Performance (%)
7.71%
Price
07.08.26
€179.88
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 7.71%. This prediction currently runs until 09.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 2.181% | 2.181% |
| iShares Core DAX® | 2.573% | 5.333% |
| iShares Nasdaq 100 | 4.858% | 0.449% |
| iShares Nikkei 225® | 5.590% | -0.586% |
| iShares S&P 500 | 3.250% | 2.500% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target raised by analysts at Royal Bank Of Canada from $217.00 to $233.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat